The Office of the U.S. Trade Representative has confirmed that there has been a “compromise reached between the four major players in discussions to waive intellectual property rights for COVID-19 vaccines.
Date:
The Office of the U.S. Trade Representative has confirmed that there has been a “compromise reached between the four major players in discussions to waive intellectual property rights for COVID-19 vaccines.